PRNewsWire · RNAZ · October 28, 2026

TransCode Therapeutics Retains Tungsten Advisors to Lead Formal Strategic Process Intended to Maximize Value of TTX-MC138 and its Oncology Portfolio

Get the app for more

Explore stock news, insights and company research.